The data presented in this article are related to the research paper entitled "peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension" [1]. Data show that the absence of peroxiredoxin-2 (Prx2) is associated with increased lung oxidation and pulmonary vascular endothelial dysfunction. Prx2 −/− mice displayed activation of the redox-sensitive transcriptional factors, NFkB and Nrf2, and increased expression of cytoprotective system such as heme-oxygenase-1 (HO-1). We also noted increased expression of both markers of vascular activation and extracellular matrix remodeling. The administration of the recombinant fusion
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The data presented in this article are related to the research paper entitled "peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension" [1] . Data show that the absence of peroxiredoxin-2 (Prx2) is associated with increased lung oxidation and pulmonary vascular endothelial dysfunction. Prx2
−/− mice displayed activation of the redox-sensitive transcriptional factors, NFkB and Nrf2, and increased expression of cytoprotective system such as heme-oxygenase-1 (HO-1). We also noted increased expression of both markers of vascular activation and extracellular matrix remodeling. PEP Prx2 significantly reduces protein oxidation in lung from exposed to prolonged hypoxia used to trigger pulmonary artery hypertension.
Data
Data show increased lung oxidation ( Fig. 1A ) and abnormal pulmonary vascular leakage in the absence of Prx2 (Fig. 1B) . This was paralleled by the activation of redox-sensitive transcriptional factors NF-kB and Nrf2 in lung from Prx2 −/− compared to wildtype animals ( Fig. 2A) . Indeed, in Prx2 Using prolonged hypoxia to trigger pulmonary artery hypertension, we observed severe lung pathologic damage and the precocious development of pulmonary artery hypertension in Prx2 −/− mice compared to wildtype animals [4] [5] [6] . This was associated with (i) marked activation of redoxrelated transcriptional factors; (ii) severe endoplasmic-reticulum stress with activation of the unfolded protein response (UPR) system; and (iii) activation of autophagy [1] .
PEP Prx2 treatment prevented the hypoxia induced protein oxidation in mice exposed to prolonged hypoxia (7 days; Fig. 3A ) and reduced the hypoxia induced increased expression of HO-1 in both mouse strains exposed to 3 days hypoxia (Fig. 3B) . Collectively, these data indicate the important role of Prx2 in lung homeostasis against hypoxia, a known trigger of lung injury.
Experimental design, materials and methods

MDA assay
MDA was determined as previously reported [7, 8] .
Measurement of BAL protein content
Bronchoalveolar lavage assay
Bronchoalveolar lavage (BAL) fluids were collected and cellular contents were recovered by centrifugation and counted by microcytometry as previously reported [6, 9] . Data are presented as means 7 SD (n ¼ 6; *p o 0.05 compared to WT mice).
Immunoblot analysis
Frozen lung from each studied group were homogenized and lysed with iced lyses buffer as previously described [3, 10, 11] . Gels were transferred to nitrocellulose membranes for immuno-blot analysis with specific antibody: anti-NFkB-phospho-S536 (93H1) (Cell Signaling Technology, Leiden, NL); anti-NFkB p65 (C22B4) (Cell Signaling Technology, Leiden, NL); anti-Nrf2-phospho-S40 (Clone EP1809Y, AbCam, Cambridge, UK); anti-Nrf2 (AbCam, Cambridge, UK); anti-Heme Oxygenase-1 (HO-1) (Santa Cruz Biotechnology, Heidelberg, Germany), anti-Endothelin-1 (ET-1) (Santa Cruz Biotechnology, Heidelberg, Germany); anti-VCAM-1 (R and D Systems, Minneapolis, MN, USA); anti-PDGF-B (AbCam, Cambridge, UK); anti-GAPDH (Sigma Aldrich, Saint Louis, MO, USA) was used as loading control. Images were acquired using Image Quant Las Mini 4000 Digital Imaging System (GE Healthcare Life Sciences). Densitometric analyses were performed using the ImageQuant TL software (GE Healthcare Life Sciences) [11] . 
Measurement of lung protein oxidation
Oxidized proteins were revealed by the Oxyblot Protein Oxidation Detection Kit (EMD Millipore). In brief, the soluble protein extracts were derivatized to 2,4-dinitrophenylhydrazone (DNP) and 1 µg was loaded on 12% SDS-PAGE, blotted and incubated with an anti-DNP antibody, followed by an HRP conjugated secondary antibody. The bound activity was revealed by ECL (GE Healthcare). Oxidized proteins were revealed by the Oxyblot Protein Oxidation Detection Kit (EMD Millipore). In brief, the soluble protein extracts were derivatized to 2,4-dinitrophenylhydrazone (DNP) and 1 ug was loaded on 12% SDS-PAGE, blotted and incubated with an anti-DNP antibody, followed by an HRP conjugated secondary antibody. The bound activity was revealed by ECL (GE Healthcare) [12] [13] [14] .
Generation of recombinant-PEP Prx2 fusion protein (PEP Prx2)
The fusion protein PEP Prx2 was generated as previously reported [2, 3] .
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